Q32 Bio (QTTB) Divestments (2022)
Q32 Bio (QTTB) recorded quarterly Divestments of $130.0 million in Q1 2022.
Q32 Bio (QTTB) Divestments (2022) Analysis & Trends
Q32 Bio's Divestments history runs 1 years deep, the most recent figure standing at $130.0 million for Q1 2022.
- In Q1 2022, Divestments changed N/A year-over-year to $130.0 million; the TTM figure through Dec 2022 stood at $130.0 million (changed N/A YoY), while the FY2022 annual figure was $130.0 million, changed N/A from the prior year.
- Divestments was $130.0 million for Q1 2022 at Q32 Bio.
- In the past five years, Divestments ranged from a high of $130.0 million in Q1 2022 to a low of $130.0 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Q32 Bio | 167.59 Mn | 116.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 130.00 Mn |